Text Size
388 studies found for:    Open Studies | "Nevus"

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Unknown † Evaluation of 20% Betulinic Acid Ointment for Treatment of Dysplastic Nevi (Moderate to Severe Dysplasia)
Condition: Dysplastic Nevus Syndrome
Intervention: Drug: 20% betulinic acid ointment
2 Unknown † Genetic Identification (ID) of Segmental Dysplastic Nevi
Condition: Segmental Dysplastic Nevi
Intervention: Procedure: Punch Biopsy
3 Not yet recruiting Classification and Longitudinal Follow-up of Common Melanocytic Nevi With in Vivo Reflectance Confocal Microscopy
Condition: Common Melanocytic Nevi
Intervention: Device: RCM imaging
4 Recruiting Pilot Study Evaluating Sulforaphane in Atypical Nevi-Precursor Lesions
Conditions: Atypical Nevi;   Melanoma
Intervention: Drug: broccoli sprout extract - sulforaphane (BSE-SFN)
5 Recruiting Potential Research Study Participant Registry
Conditions: Acne;   Actinic Keratosis;   Dysplastic Nevi;   Eczema;   Psoriasis;   Skin Cancer;   Rosacea;   Leg Ulcers;   Foot Ulcers;   Atopic Dermatitis
Intervention:
6 Recruiting Study of the Genetic and Epigenetic Causes of Recurrent Hydatidiform Moles
Condition: Hydatidiform Moles
Intervention:
7 Unknown † Early Diagnosis of Malignant Transformation of Pigmentary Skin Lesions
Conditions: Malignant Melanoma;   Pigmented Nevi;   Skin Neoplasm
Intervention:
8 Recruiting A Comparison of Single Versus Double Evacuation for Treatment of Hydatidiform Mole
Condition: Hydatidiform Mole
Intervention: Procedure: Suction and evacuation
9 Unknown † Using High Resolution Function Imaging To Detect Melanoma and Dysplastic Nevi
Condition: Melanoma
Intervention:
10 Recruiting Trial Comparing the Effects of Intermittent Vismodegib Versus Photodynamic Therapy in Patients With Multiple Basal Cell Carcinomas
Conditions: Basal Cell Nevus Syndrome;   Gorlin's Syndrome
Interventions: Drug: GDC-0449;   Procedure: Aminolevulinic acid %20 topical solution + blue light
11 Recruiting Clinical and Histopathologic Characteristics of BAP1 Mutations
Conditions: Malignant Pleural Mesothelioma (MPM);   Choroidal Nevus;   Primary Uveal Melanoma (UM);   Metastatic Uveal Melanoma (UM)
Intervention: Other: tumor specimens
12 Recruiting Oral N-acetylcysteine for Protection of Human Nevi Against UV-induced Oxidative Stress/Damage in Vivo
Condition: Patients at Risk for Melanoma
Interventions: Drug: N-acetylcysteine;   Other: Placebo arm
13 Recruiting An Observational Study of Treatment Patterns and Effectiveness and Safety Outcomes in Advanced Basal Cell Carcinoma and Basal Cell Carcinoma Nevus Syndrome Patients(RegiSONIC)
Condition: Basal Cell Carcinoma
Intervention:
14 Unknown † Optical Coherence Tomography of Retinal Abnormalities Associated With Choroidal Nevus, Choroidal Melanoma and Choroidal Melanoma Treated With Iodine-125 Brachytherapy
Condition: Ocular Melanoma
Intervention:
15 Recruiting Efficacy, Safety and Pharmacokinetics of Oral LDE225 in Treatment of Patients With Nevoid Basal Cell Carcinoma Syndrome
Conditions: Basal Cell Carcinoma;   Gorlin Syndrome;   Nevoid Basal Cell Carcinoma Syndrome
Interventions: Drug: LDE225;   Drug: Placebo
16 Recruiting Family Study of Melanoma in Italy
Condition: Melanoma
Intervention:
17 Unknown † Melanoma Inhibitory Activity (MIA): A Serological Marker for Metastatic Uveal Melanoma
Conditions: Melanoma;   Radiotherapy;   Metastatic Disease
Intervention: Procedure: Treatment of metastatic disease
18 Unknown † Treatment Of Radiation Retinopathy Trial
Condition: Uveal Melanoma
Interventions: Drug: ranibizumab;   Drug: triamcinolone acetonide;   Other: sham
19 Recruiting A Phase I Study of Intralesional Bacillus Calmette-Guerin (BCG) and Followed by Ipilimumbab Therapy in Patients With Advanced Metastatic Melanoma
Condition: Metastatic Melanoma
Interventions: Biological: Bacillus Calmette-Guérin (BCG) vaccine;   Drug: Ipilimumab
20 Recruiting Phase I/II Study to Assess the Safety and Activity of Enhanced TCR Transduced Autologous T Cells in Metastatic Melanoma
Condition: Melanoma
Interventions: Biological: MAGE-3;   Biological: NY-ESO-1
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years